Drug innovations and welfare measures computed from market demand : the case of anti-cholesterol drugs
Year of publication: |
2012
|
---|---|
Authors: | Dunn, Abe |
Published in: |
American economic journal : a journal of the American Economic Association. - Nashville, Tenn. : Assoc., ISSN 1945-7782, ZDB-ID 2442384-1. - Vol. 4.2012, 3, p. 167-189
|
Subject: | Arzneimittel | Pharmaceuticals | Innovation | Produktqualität | Product quality | Preis | Price | Nachfrage | Demand | Diskrete Entscheidung | Discrete choice | Wohlfahrtsanalyse | Welfare analysis | USA | United States | 1996-2007 |
-
Dunn, Abe, (2011)
-
Perverse incentives in the medicare prescription drug benefit
McAdams, David, (2006)
-
Pharmaceutical industry, drug quality and regulation : evidence from US and Italy
Atella, Vincenzo, (2008)
- More ...
-
Dunn, Abe, (2009)
-
Dunn, Abe, (2008)
-
The value of coverage in the Medicare advantage insurance market
Dunn, Abe, (2010)
- More ...